MediWound (MDWD) Fundamental Analysis: Revenue, Earnings & Valuation

1.92 / 10

Underperform

Fundamentally, MDWD scores 1.9/10, reflecting declining operating revenue (‑16% YoY) and high cost‑of‑sales (≈81%). Positive aspects include a solid current‑liabilities ratio (60%) and strong interest coverage (35×). Overall, the fundamentals are underperforming.

Analysis Checks(5/10)

Revenue-MV

Value-2.97

Score1/3

Weight44.31%

1M Return4.09%

Total operating revenue (YoY growth rate %)

Value-16.14

Score1/3

Weight-3.50%

1M Return-0.38%

Inventory turnover ratio

Value4.04

Score2/3

Weight-10.17%

1M Return-1.18%

Current liabilities / Total liabilities (%)

Value60.31

Score2/3

Weight3.45%

1M Return0.36%

PB-ROE

Value1.24

Score2/3

Weight83.23%

1M Return7.29%

Long-term debt to working capital ratio (%)

Value0.49

Score3/3

Weight7.80%

1M Return0.87%

Interest coverage ratio (EBIT / Interest expense) (%)

Value35.11

Score2/3

Weight-10.34%

1M Return-1.17%

Operating revenue (YoY growth rate %)

Value-16.14

Score1/3

Weight-2.75%

1M Return-0.30%

Cost of sales ratio (%)

Value80.81

Score1/3

Weight-52.58%

1M Return-7.95%

Asset-MV

Value-0.55

Score0/3

Weight40.55%

1M Return4.00%

Is MDWD fundamentally strong?

MDWD scores 1.92/10 on fundamentals and holds a Premium valuation at present. Backed by its -63.86% ROE, -140.80% net margin, -8.94 P/E ratio, 4.89 P/B ratio, and 30.69% earnings growth, these metrics solidify its Underperform investment rating.